Publish date:

Jim Cramer's Stop Trading! Buy Monsanto

Cramer likes the ag sector.

The agriculture rally is far from over, Jim Cramer said Tuesday on CNBC's Stop Trading! segment.

Cramer said a Morgan Stanley upgrade on





(BG) - Get Bunge Limited Report

and other agriculture plays is wise because the rally in these stocks is only beginning. Cramer believes Monsanto is turning into a biotech but continues to be valued as something dowdier. He said the stock could soar to $75 from a recent $60.

Cramer also said


TheStreet Recommends


is due for a split-up, and that the retail conglomerate's Bath & Body Works chain is a great value play.

At the time of publication, Cramer had no position in stocks mentioned.

Jim Cramer is a director and co-founder of He contributes daily market commentary for's sites and serves as an adviser to the company's CEO. Outside contributing columnists for and, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for

Action Alerts PLUS. Watch Cramer on "Mad Money" weeknights on CNBC. Click

here to order Cramer's latest book, "Mad Money: Watch TV, Get Rich," click

here to order his book, "Real Money: Sane Investing in an Insane World," click

here to get his second book, "You Got Screwed!" and click

here to order Cramer's autobiography, "Confessions of a Street Addict." While he cannot provide personalized investment advice or recommendations, he invites you to send comments on his column by

clicking here. has a revenue-sharing relationship with Traders' Library under which it receives a portion of the revenue from Traders' Library purchases by customers directed there from